Anzeige
Mehr »
Login
Freitag, 29.03.2024 Börsentäglich über 12.000 News von 687 internationalen Medien
NurExone Biologic: Technisches (täglich, wöchentlich, monatlich) & Analysten "Strong Buy"-Rating!
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche
ACCESSWIRE
472 Leser
Artikel bewerten:
(2)

ProPhotonix Limited Announces 5-Year Master Purchase Agreement - Fortune 50 CGLM

Five-Year Master Purchase Agreement from a Fortune 50 conglomerate

SALEM, NH / ACCESSWIRE / October 10, 2019 / ProPhotonix Limited, (OTC: STKR; London Stock Exchange - AIM: PPIX), a designer and manufacturer of LED illumination systems and laser diode modules with operations in Ireland and the United Kingdom, today announces the award of a five year supply agreement, for custom LED illumination devices and maintenance products, from a Fortune 50 conglomerate (the "Agreement").

The custom LED illumination devices feature a unique design incorporating multiwavelength configurations and automated software to control spectral balance and the automated configuration of hardware deployment.

The Agreement runs for five years unless otherwise terminated pursuant to various provisions of the Agreement. Whilst the Agreement does not stipulate or require that the customer makes any purchases, ProPhotonix anticipates that expected revenue could equate to approximately $1 million per annum.

Commenting on the Agreement, Tim Losik, President and CEO of ProPhotonix stated:

"The Agreement is the culmination of nearly four years of work with our customer, ultimately delivering innovative solutions and capability that will provide them with a superior market solution. These solutions do more than just provide light - they communicate with the control features of the entire system through our custom software and design features. Every engineering discipline at ProPhotonix including optics, electronics, mechanics, materials, software and manufacturing, participated from concept to commercialization. With over 15 years' experience in custom LED and laser module design, ProPhotonix delivers solutions across a wide range of industries including the dental, medical and pharmaceutical industries."

Contact:

ProPhotonix Limited

Tim Losik, President & CEO

Tel: +1 603 893 8778

ir@prophotonix.com

Cantor Fitzgerald Europe

(Nominated Adviser and Broker) Tel: +44 (0)207 894 7000

David Foreman (Corporate Finance)

Keith Dowsing (Equity Sales)

About ProPhotonix

ProPhotonix Limited, headquartered in Salem, New Hampshire, is a high technology designer and manufacturer of diode-based laser modules and LED systems for industry leading OEMs and medical equipment companies. In addition, the Company distributes premium diodes for Ushio, Osram, QSI, Panasonic, and Sony. The Company serves a wide range of markets including the machine vision, industrial inspection, security, and medical markets. ProPhotonix has offices and subsidiaries in the U.S., Ireland, U.K., and Europe. For more information about ProPhotonix and its innovative products, visit the Company's web site at www.prophotonix.com.

Cautionary Statement

This press release contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934. All statements other than statements of historical fact, including without limitation, those with respect to ProPhotonix's goals, plans and strategies set forth herein are forward-looking statements. The following important factors and uncertainties, among others, could cause actual results to differ materially from those described in these forward-looking statements: uncertainty that cash balances will be sufficient to allow ProPhotonix to meet all of its business goals; uncertainty that ProPhotonix's new products will gain market acceptance; the risk that delays and unanticipated expenses in developing new products could delay the commercial release of those products and affect revenue estimates; the risk that one of our competitors could develop and bring to market a technology that is superior to those products that we are currently developing; and ProPhotonix's ability to capitalize on its significant research and development efforts by successfully marketing those products that the Company develops. Forward-looking statements represent management's current expectations and are inherently uncertain. All Company, brand, and product names are trademarks or registered trademarks of their respective holders. ProPhotonix undertakes no duty to update any of these forward-looking statements.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

SOURCE: ProPhotonix Limited



View source version on accesswire.com:
https://www.accesswire.com/562681/ProPhotonix-Limited-Announces-5-Year-Master-Purchase-Agreement--Fortune-50-CGLM

Großer Dividenden-Report 2024 von Dr. Dennis Riedl
Der kostenlose Dividenden-Report zeigt ganz genau, wo Sie in diesem Jahr zuschlagen können. Das sind die Favoriten von Börsenprofi Dr. Dennis Riedl
Jetzt hier klicken
© 2019 ACCESSWIRE
Werbehinweise: Die Billigung des Basisprospekts durch die BaFin ist nicht als ihre Befürwortung der angebotenen Wertpapiere zu verstehen. Wir empfehlen Interessenten und potenziellen Anlegern den Basisprospekt und die Endgültigen Bedingungen zu lesen, bevor sie eine Anlageentscheidung treffen, um sich möglichst umfassend zu informieren, insbesondere über die potenziellen Risiken und Chancen des Wertpapiers. Sie sind im Begriff, ein Produkt zu erwerben, das nicht einfach ist und schwer zu verstehen sein kann.